• WellDoc Announces Providence Health Services’ Implementation of BlueStar®

    WellDoc Announces Providence Health Services’ Implementation of BlueStar® WellDoc Announces Providence Health Services’ Implementation of BlueStar®
  • WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Within Samsung Health

    WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Within Samsung Health WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Within Samsung Health
  • Transforming the Treatment of Chronic Disease Through Science, Digital Engagement, and Proven Outcomes

    Transforming the Treatment of Chronic Disease Through Science, Digital Engagement, and Proven Outcomes Transforming the Treatment of Chronic Disease Through Science, Digital Engagement, and Proven Outcomes
  • Get Industry Insights From WellDoc’s Thought Leaders

    Get Industry Insights From WellDoc’s Thought Leaders Get Industry Insights From WellDoc’s Thought Leaders
  • Solera Health and WellDoc Announce Partnership

    Solera Health and WellDoc Announce Partnership Solera Health and WellDoc Announce Partnership
  • Truven Health Analytics Correlates BlueStar’s A1C Reductions to Cost Savings

    Truven Health Analytics Correlates BlueStar’s A1C Reductions to Cost Savings Truven Health Analytics Correlates BlueStar’s A1C Reductions to Cost Savings
  • Meet Our Clinical Team

    Meet Our Clinical Team Meet Our Clinical Team

Strategic Partners

BlueStar®

Our digital health solutions are changing the face of chronic disease management, reducing costs, improving clinical outcomes, and creating hope and change for individuals living with chronic diseases.

While our current solution, BlueStar, is a robust, highly intelligent app focused on type 2 diabetes, we are also pursuing digital solutions in other therapeutic areas.

BlueStar®

Clinical Evidence

Our clinical evidence shows a mean reduction of 1.7 to 2.0 point A1C drop for individuals living with type 2 diabetes who used BlueStar.

Clinical Evidence

Quantifying the Elusive Economic Value of Digital Health

BlueStar results in savings, on average, between $254 to $271 per user per month (A1C < 8). Based on analysis by Truven Health Analytics, part of IBM Watson Health

Truven Health Analytics

Investors

  • Global Health Innovation
  • LifeScan Johnson & Johnson
  • Samsung
  • Adage Capital Management
  • Alexandria Capital
  • AMV
  • DigiTx Partners
  • Excel Venture Management”
  • RS Investments

Read More About Us